does tirzepatide cause inflammation Causes and consequences of discontinuation of GLP1RAs or Tirzepatide as a Potential Disease-Modifying
Description
A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science up to August 2025
Background: GLP-1 RA (glucagon-like peptide-1 receptor agonists), including semaglutide, may reduce stroke risk in people with type 2 diabetes
The experimental (hops) group also reported a reduction in cravings for savory and sweet foods compared to placebo [1]
This is one of the focuses for the upcoming ATTAIN-PAD trial!
From irregular cycles to heavier periods, and a crucial warning about the oral pill
